Pattin appointed clinical associate professor in the Division of Outcomes and Practice Advancement

Pattin comes to UB from The University of Toledo (UT) College of Pharmacy and Pharmaceutical Sciences, where he served as an associate professor of Pharmacy Practice specializing in community practice and directed clinical services at various practice sites within the Kroger Company of Michigan and Meijer Pharmacy. He taught pharmacy law within the PharmD curriculum at UT and in 2020 earned recognition when 100% of UT PharmD students passed the Ohio Multistate Pharmacy Jurisprudence Exam (MPJE). With more than a decade of experience in community pharmacy practice, Pattin’s background bridges a gap in UB SPPS offerings.  

“Dr. Pattin brings a new dimension to our faculty,” says William Prescott, PharmD, department chair, clinical professor, Department of Pharmacy Practice. “Two-thirds of our graduates indicate plans to enter community pharmacy upon graduation, yet we’ve not had a faculty member focused in this area since I joined the school in 2004. Dr. Pattin’s background and experience will help fill this void.”  

Pattin earned his Doctor of Pharmacy degree from the University of Toledo in 2009 and completed a PGY1 Community Pharmacy residency with the University of Toledo from 2009 to 2010. Following a 5-year post at Wayne State University as a clinical assistant professor, he returned to the University of Toledo in 2015 and was promoted to an associate professor with tenure in 2021.

“Dr. Pattin is well positioned to advance community pharmacy practice in Western New York and the state,” says Calvin Meaney, PharmD, clinical associate professor and interim division head, Division of OPA, Department of Pharmacy Practice. “Our students will greatly benefit from his dynamic teaching style and personalized approach. I am excited to welcome Dr. Pattin to our Division of Outcomes and Practice Advancement and look forward to the positive impact he will have on our students, community, and profession.”

Pattin’s research interests include studying issues related to African Americans’ use of pharmacy-based immunization services and the impact of medication synchronization on medication adherence and cardiovascular disease. In 2016, Pattin was accepted in a competitive research training program funded by the National Heart, Lung, and Blood Institute (NHLBI) to improve grantsmanship skills and competitiveness for funding from the National Institutes of Health (NIH).

At UB, Pattin will maintain practice sites in local independent pharmacies, where he’ll have an opportunity to mentor students who plan to practice in the community setting.

“Dr. Pattin will be joining our group of independent community practice sites: Middleport Family Health, Wurlitzer Family Pharmacy, Summit Park Pharmacy and Transit Hill Pharmacy to help expand our PGY1 community pharmacy residency program and conduct research on the cost saving role of expanded pharmacist services in our patient-focused, face-to-face community pharmacy practice site,” explains Stephen Giroux, BS ’81, president and Chief Executive Officer, Middleport Family Health Center and community practice partner, UB School of Pharmacy and Pharmaceutical Sciences. “This research will help enhance our support of UB PharmD student rotations and our residency program so we can better prepare graduates for more robust community practice opportunities.”

For Pattin, the potential impact he’ll have on UB pharmacy students’ research and education is what drew him to this position.

“Throughout my career I have always done my best to impact students and the community in meaningful ways,” he explains. “This practice site will allow us to evaluate impactful models and outcomes from our patient care services. My initial gravitation toward UB SPPS was its extraordinary educational and research programs, and I’m looking forward to having a positive impact on both.”